1. Medtech Insight
  2. >>Policy & Regulation

US House Panelists Fault CMS For Cutbacks To Joint Replacement Bundled-Pay Program

 
• By Sue Darcey

The US Centers for Medicare and Medicaid Services' decision last fall to limit a joint replacement bundled program met with considerable pushback from lawmakers this week.

Capitol House

House Ways and Means Committee members – both Democrat and Republican – critiqued the Centers for Medicare and Medicaid Services' plans at a March 21 hearing to completely overhaul its value-based payment program, and its decision last fall to considerably scale-back a popular joint replacement, value-based payment program.

Members at the hearing grilled Demetrios Kouzoukas, CMS principal deputy administrator, and Kate Goodrich, CMS chief medical officer, on recent...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

More from Policy & Regulation

Increasing Safety Concerns Spur Scrutiny of Device Plastics Use

 
• By Elizabeth Orr

With new regulations limiting the use of plastics popping up worldwide, the medtech industry sees arguments on both sides. Some argue hasty bans of PFAS ("forever chemicals") would harm patients, while others say phthalates should be phased out to protect the public.

With LDT Rule DOA, Could FDA Shift Focus To RUOs?

 
• By Brian Bossetta

Now that the US FDA has chosen not to appeal a March ruling effectively killing the agency’s efforts to regulate lab-developed tests as medical devices, will the agency adopt a different strategy to flex its regulatory muscle?

US FDA Unveils Plans To Consolidate Support Services

 
• By Derrick Gingery and Sue Sutter

Commissioner Martin Makary told staff that plans are being developed to centralize HR, IT, travel and other functions, which were heavily impacted by the 1 April reduction-in-force.